TP53 and myelodysplastic syndrome: Biallelic TP53 alterations appear to drive myeloid neoplasms by different mechanisms than monoallelic ones: MDS-biTP53 cases have significantly less additional driver mutations and higher numbers of copy number abnormalities and cytogenetic lesions.